07:00 , Oct 13, 1997 |  BioCentury  |  Finance

Burgeoning Euro venture funds

Europe's public markets for bioscience companies may be in the doldrums at the moment, but the European appetite for private investments probably has never been higher. In the past year, there has been an unprecedented...